Join us to explore the latest developments of proton ConformalFLASH therapy, and to discover how ConformalFLASH is poised to revolutionize radiotherapy by leveraging the unique physical advantages of the proton Bragg peak and biological sparing effects of Flash. 

During this webinar, you will have the opportunity to gain valuable insights from clinical and industry experts, including Dr. Michele Kim from the University of Pennsylvania, along with Yohan Godart and Jarrick Nys, research experts at IBA. They will share their expertise on the progress of ultra-high dose rate proton therapy and discuss the groundbreaking achievement of the first full end-to-end treatment of a canine patient with ConformalFLASH on Proteus® technology, matching clinical tolerances, from treatment planning to quality assurance.

Don't miss out on this opportunity to stay at the forefront of proton therapy advancements with IBA!